HWA
ABBV icon

HHM Wealth Advisors’s AbbVie ABBV Stock Holding History

HHM Wealth Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.37M Buy
9,421
+36
+0.4% +$7.75K 0.24% 38
2026
Q1 		$2.04M Buy
9,385
+554
+6% +$123K 0.23% 39
2025
Q4 		$2.02M Sell
8,831
-50
-0.6% -$11.4K 0.24% 43
2025
Q3 		$2.06M Buy
8,881
+67
+0.8% +$13.6K 0.24% 38
2025
Q2 		$1.64M Sell
8,814
-219
-2% -$40.7K 0.19% 51
2025
Q1 		$1.89M Buy
9,033
+6
+0.1% +$1.17K 0.25% 42
2024
Q4 		$1.6M Buy
9,027
+3,058
+51% +$562K 0.22% 50
2024
Q3 		$1.18M Sell
5,969
-5
-0.1% -$933 0.17% 55
2024
Q2 		$1.02M Buy
5,974
+1,717
+40% +$284K 0.15% 60
2024
Q1 		$775K Hold
4,257
– – 0.13% 59
2023
Q4 		$660K Buy
4,257
+370
+10% +$53.9K 0.11% 63
2023
Q3 		$579K Buy
3,887
+200
+5% +$29.4K 0.11% 64
2023
Q2 		$497K Hold
3,687
– – 0.09% 75
2023
Q1 		$588K Hold
3,687
– – 0.12% 63
2022
Q4 		$596K Sell
3,687
-10
-0.3% -$1.53K 0.14% 60
2022
Q3 		$496K Sell
3,697
-1,544
-29% -$222K 0.13% 57
2022
Q2 		$803K Sell
5,241
-139
-3% -$21.2K 0.21% 41
2022
Q1 		$872K Buy
5,380
+1,502
+39% +$218K 0.2% 41
2021
Q4 		$525K Buy
3,878
+64
+2% +$7.56K 0.13% 66
2021
Q3 		$411K Buy
3,814
+638
+20% +$72.9K 0.11% 74
2021
Q2 		$358K Hold
3,176
– – 0.1% 82
2021
Q1 		$344K Buy
3,176
+344
+12% +$36.8K 0.11% 75
2020
Q4 		$303K Hold
2,832
– – 0.1% 74
2020
Q3 		$248K Hold
2,832
– – 0.1% 75
2020
Q2 		$278K Sell
2,832
-251
-8% -$22.1K 0.12% 67
2020
Q1 		$235K Buy
3,083
+600
+24% +$51.1K 0.11% 68
2019
Q4 		$220K Buy
+2,483
New +$206K 0.11% 77

Other funds holding ABBV

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return
AAIS
ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return

HHM Wealth Advisors's ABBV Position: Q2 2026 in Review

HHM Wealth Advisors increased its AbbVie (ABBV) stake by 0.38% in Q2 2026, buying an estimated $7.75K and bringing the position to 9,421 shares worth $2.37M. The position accounts for 0.24% of the portfolio, ranked #38.

HHM Wealth Advisors first reported a position in ABBV in Q4 2019 and has held it in 27 quarters since. 1,482 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • HHM Wealth Advisors held 9,421 shares of AbbVie worth $2.37M as of Q2 2026.
  • HHM Wealth Advisors bought 36 AbbVie shares in Q2 2026, an estimated $7.75K.
  • AbbVie made up 0.24% of HHM Wealth Advisors's portfolio in Q2 2026, its #38 holding.
  • HHM Wealth Advisors first reported a position in AbbVie in Q4 2019 and has held it in 27 quarters since.
  • 1,482 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on HHM Wealth Advisors's 13F filing for Q2 2026, filed 13 Jul 2026.